News
‘Deal with the Devil’: Harvard Medical School Faculty Grapple with Increased Industry Research Funding
News
As Dean Long’s Departure Looms, Harvard President Garber To Appoint Interim HGSE Dean
News
Harvard Students Rally in Solidarity with Pro-Palestine MIT Encampment Amid National Campus Turmoil
News
Attorneys Present Closing Arguments in Wrongful Death Trial Against CAMHS Employee
News
Harvard President Garber Declines To Rule Out Police Response To Campus Protests
The first spring production ever attempted by the Cercle Francais will be performed in the Copley Theatre, formerly known as the Toy, at 188 Dartmouth street, Boston, this evening at 8 o'clock. Two plays comprise the offering, "Servir," and "Edgar et sa Bonne." They will be performed by the Cercle Francais only once at the Copley Theatre.
Following the performance there will be dancing in the ballroom of the theatre. Tickets to the play are now on sale at $1.50, $1, 75 cents, and 50 cents each at Herrick's and the Co-operative Branch, or may be obtained from H. L. Carroll '18, Dunster 26. Tickets will also be on sale at the Copley Theatre all day.
The cast for the plays is composed of members of the two Cercles Francais, in the University and in Radcliffe. Students from the latter college will take the feminine roles.
"Servir" is a war drama in two acts, by Henri Lavedan, and "Edgar et sa Bonne," by Labiche, is a one-act farce. The "Servir" was first produced in Paris in 1913 at the Theatre Sarah Bernhardt, and, with the foremost of modern French actors, M. Gintry, in the chief role, was highly successful. It was written while the trouble between France and Morocco was still going on, and, very appropriately to the talk of today, it shows the struggle between a militarist father of the old school and a pacifist son with modern ideas. Although the play was composed before the outbreak of the present European war, the play ends with the declaration of war between France and Germany.
The casts for the plays are as follows:
Want to keep up with breaking news? Subscribe to our email newsletter.